T-cell

(redirected from T-cells)
Also found in: Thesaurus, Medical, Encyclopedia.
Related to T-cells: Cytokines, B-cells

T-cell

n
(Biochemistry) another name for T-lymphocyte
Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014
References in periodicals archive ?
[USA], May 18 (ANI): Researchers have shown how skin vaccination can generate protective CD8 T-cells that are recruited to the genital tissues and could be used as a vaccination strategy for sexually transmitted infections (STIs).
The limitation so far has been the presence of the CS1 target on the surface of T-cells, which has hindered the access to CAR-Ts and bispecific antibodies.
To the Editor: Regulatory T-cells (Tregs), a subset of CD4+ T-cells, have the capacity to actively suppress immune responses and play a pivotal role in sepsis-induced immunosuppression.[1] B- and T-lymphocyte attenuator (BTLA) is a co-inhibitory receptor that is known to potently inhibit CD4+ T-cell function and to block prosurvival signaling in CD4+ T-cells.[2] Tregs constitutively express BTLA.
When there is an infection, T-Cells are deployed to the site of the infection where they detect and destroy the virus-infected cells.
Bioengineers at the Georgia Institute of Technology have installed a heat-sensitive switch into T-cells that can activate the T-cells when heat turns the switch on.
While the exact causes of autoimmune disease remain unclear, scientists know that these diseases, ranging from MS to asthma, have something in common--the failure of helper T-cells to develop into regulatory T-cells, also known as Tregs.
The study used two control variables in fighting HIV with the inclusion of the [CD8.sup.+] T-cells. However, the study has some shortcomings; for instance, the study suggested that activated [CD8.sup.+] T-cells kill the HIV virions and also the infected cells.
DCs are the most potent antigen-presenting cells in terms of activation of naive T-cells and play a critical role in the initiation of both primary and secondary immune responses to pathogens [6, 7].
The company's TriTAC molecules are half-life extended and designed to simultaneously bind to cancer cells and T-cells, triggering those T-cells to attack the targeted cancer cells.
Chimeric antigen receptor T-cell therapy, or CAR-T, is a new approach involving the re-engineering of a patient's T-cells so that they can better find and destroy cancer cells.